nodes	percent_of_prediction	percent_of_DWPC	metapath
Perphenazine—CYP1A2—Imiquimod—skin cancer	0.0946	0.137	CbGbCtD
Perphenazine—CYP2C8—Vismodegib—skin cancer	0.0847	0.123	CbGbCtD
Perphenazine—CYP2C19—Vismodegib—skin cancer	0.071	0.103	CbGbCtD
Perphenazine—CYP2C9—Vismodegib—skin cancer	0.0591	0.0859	CbGbCtD
Perphenazine—CYP1A2—Vemurafenib—skin cancer	0.0518	0.0753	CbGbCtD
Perphenazine—CYP3A4—Temozolomide—skin cancer	0.0495	0.072	CbGbCtD
Perphenazine—CYP3A4—Imiquimod—skin cancer	0.0495	0.072	CbGbCtD
Perphenazine—CYP2D6—Vemurafenib—skin cancer	0.0427	0.0621	CbGbCtD
Perphenazine—CYP1A2—Dacarbazine—skin cancer	0.0397	0.0577	CbGbCtD
Perphenazine—CYP3A4—Vismodegib—skin cancer	0.0343	0.0499	CbGbCtD
Perphenazine—CYP2C8—Fluorouracil—skin cancer	0.0301	0.0437	CbGbCtD
Perphenazine—CYP3A4—Vemurafenib—skin cancer	0.0271	0.0395	CbGbCtD
Perphenazine—CYP1A2—Fluorouracil—skin cancer	0.0233	0.0339	CbGbCtD
Perphenazine—CYP2C9—Fluorouracil—skin cancer	0.021	0.0305	CbGbCtD
Perphenazine—CYP3A4—Docetaxel—skin cancer	0.00931	0.0135	CbGbCtD
Perphenazine—Edema cerebral—Temozolomide—skin cancer	0.00695	0.0515	CcSEcCtD
Perphenazine—HRH1—nose—skin cancer	0.00594	0.0607	CbGeAlD
Perphenazine—Amenorrhoea—Vismodegib—skin cancer	0.00387	0.0287	CcSEcCtD
Perphenazine—Brain oedema—Temozolomide—skin cancer	0.00376	0.0279	CcSEcCtD
Perphenazine—CALM2—ear—skin cancer	0.00373	0.0381	CbGeAlD
Perphenazine—CALM1—ear—skin cancer	0.00371	0.0379	CbGeAlD
Perphenazine—DRD1—nerve—skin cancer	0.00365	0.0373	CbGeAlD
Perphenazine—CALM2—nerve—skin cancer	0.00235	0.024	CbGeAlD
Perphenazine—HTR2A—hindlimb—skin cancer	0.00234	0.0239	CbGeAlD
Perphenazine—CALM1—nerve—skin cancer	0.00233	0.0239	CbGeAlD
Perphenazine—HTR7—nerve—skin cancer	0.00228	0.0233	CbGeAlD
Perphenazine—Slurred speech—Fluorouracil—skin cancer	0.00221	0.0164	CcSEcCtD
Perphenazine—Parkinsonism—Fluorouracil—skin cancer	0.00218	0.0161	CcSEcCtD
Perphenazine—DRD2—nerve—skin cancer	0.00216	0.022	CbGeAlD
Perphenazine—HTR2A—appendage—skin cancer	0.00201	0.0205	CbGeAlD
Perphenazine—CALM2—endothelium—skin cancer	0.002	0.0204	CbGeAlD
Perphenazine—CALM1—endothelium—skin cancer	0.00199	0.0203	CbGeAlD
Perphenazine—CALM2—hair follicle—skin cancer	0.00196	0.0201	CbGeAlD
Perphenazine—HTR7—endothelium—skin cancer	0.00194	0.0198	CbGeAlD
Perphenazine—Sudden death—Fluorouracil—skin cancer	0.00194	0.0143	CcSEcCtD
Perphenazine—Lupus erythematosus—Docetaxel—skin cancer	0.00192	0.0142	CcSEcCtD
Perphenazine—AOX1—nipple—skin cancer	0.00188	0.0192	CbGeAlD
Perphenazine—CALM2—blood vessel—skin cancer	0.00184	0.0188	CbGeAlD
Perphenazine—CALM1—blood vessel—skin cancer	0.00183	0.0187	CbGeAlD
Perphenazine—HTR7—blood vessel—skin cancer	0.00179	0.0183	CbGeAlD
Perphenazine—Photosensitivity—Vemurafenib—skin cancer	0.00174	0.0129	CcSEcCtD
Perphenazine—CYP2C18—mammalian vulva—skin cancer	0.00174	0.0178	CbGeAlD
Perphenazine—CALM3—nipple—skin cancer	0.0017	0.0173	CbGeAlD
Perphenazine—Eczema—Imiquimod—skin cancer	0.00145	0.0107	CcSEcCtD
Perphenazine—Muscle spasms—Vismodegib—skin cancer	0.00143	0.0106	CcSEcCtD
Perphenazine—Nasal congestion—Imiquimod—skin cancer	0.00143	0.0106	CcSEcCtD
Perphenazine—Extrapyramidal disorder—Temozolomide—skin cancer	0.00143	0.0106	CcSEcCtD
Perphenazine—HTR2A—nerve—skin cancer	0.00142	0.0145	CbGeAlD
Perphenazine—Cholestasis—Temozolomide—skin cancer	0.00142	0.0105	CcSEcCtD
Perphenazine—Dermatitis exfoliative—Imiquimod—skin cancer	0.00138	0.0102	CcSEcCtD
Perphenazine—CALM2—nipple—skin cancer	0.00133	0.0136	CbGeAlD
Perphenazine—Lethargy—Imiquimod—skin cancer	0.00133	0.00984	CcSEcCtD
Perphenazine—CALM1—nipple—skin cancer	0.00133	0.0135	CbGeAlD
Perphenazine—CALM2—neck—skin cancer	0.00132	0.0135	CbGeAlD
Perphenazine—CALM1—neck—skin cancer	0.00131	0.0134	CbGeAlD
Perphenazine—Eosinophilia—Vemurafenib—skin cancer	0.00131	0.00968	CcSEcCtD
Perphenazine—Systemic lupus erythematosus—Docetaxel—skin cancer	0.00129	0.00956	CcSEcCtD
Perphenazine—HTR7—neck—skin cancer	0.00128	0.0131	CbGeAlD
Perphenazine—Liver injury—Temozolomide—skin cancer	0.00128	0.00946	CcSEcCtD
Perphenazine—Urinary retention—Imiquimod—skin cancer	0.00124	0.00917	CcSEcCtD
Perphenazine—Amenorrhoea—Temozolomide—skin cancer	0.00122	0.00906	CcSEcCtD
Perphenazine—HTR2A—endothelium—skin cancer	0.00121	0.0124	CbGeAlD
Perphenazine—Photosensitivity reaction—Vemurafenib—skin cancer	0.0012	0.00892	CcSEcCtD
Perphenazine—HTR6—head—skin cancer	0.00116	0.0119	CbGeAlD
Perphenazine—HTR2A—blood vessel—skin cancer	0.00112	0.0114	CbGeAlD
Perphenazine—AOX1—mammalian vulva—skin cancer	0.0011	0.0112	CbGeAlD
Perphenazine—Pancytopenia—Imiquimod—skin cancer	0.00107	0.00792	CcSEcCtD
Perphenazine—Decreased appetite—Vismodegib—skin cancer	0.00106	0.00782	CcSEcCtD
Perphenazine—Dysarthria—Fluorouracil—skin cancer	0.00105	0.00776	CcSEcCtD
Perphenazine—Oedema peripheral—Vemurafenib—skin cancer	0.00104	0.00771	CcSEcCtD
Perphenazine—Constipation—Vismodegib—skin cancer	0.00104	0.00769	CcSEcCtD
Perphenazine—Pain—Vismodegib—skin cancer	0.00104	0.00769	CcSEcCtD
Perphenazine—CYP1A2—nipple—skin cancer	0.00103	0.0106	CbGeAlD
Perphenazine—Photosensitivity reaction—Imiquimod—skin cancer	0.00103	0.00761	CcSEcCtD
Perphenazine—Throat sore—Docetaxel—skin cancer	0.000992	0.00735	CcSEcCtD
Perphenazine—CALM3—mammalian vulva—skin cancer	0.00099	0.0101	CbGeAlD
Perphenazine—Oropharyngeal discomfort—Docetaxel—skin cancer	0.000983	0.00728	CcSEcCtD
Perphenazine—Dermatitis contact—Fluorouracil—skin cancer	0.000979	0.00725	CcSEcCtD
Perphenazine—HRH1—nipple—skin cancer	0.000967	0.00988	CbGeAlD
Perphenazine—ADRA2A—nipple—skin cancer	0.000949	0.00971	CbGeAlD
Perphenazine—CALM2—connective tissue—skin cancer	0.000944	0.00965	CbGeAlD
Perphenazine—AOX1—female reproductive system—skin cancer	0.000942	0.00962	CbGeAlD
Perphenazine—CALM1—connective tissue—skin cancer	0.00094	0.00961	CbGeAlD
Perphenazine—Photophobia—Fluorouracil—skin cancer	0.00093	0.00689	CcSEcCtD
Perphenazine—Erythema—Vemurafenib—skin cancer	0.000919	0.00681	CcSEcCtD
Perphenazine—HTR7—connective tissue—skin cancer	0.000918	0.00939	CbGeAlD
Perphenazine—CALM2—epithelium—skin cancer	0.000896	0.00916	CbGeAlD
Perphenazine—CALM1—epithelium—skin cancer	0.000892	0.00912	CbGeAlD
Perphenazine—Lethargy—Dactinomycin—skin cancer	0.00088	0.00652	CcSEcCtD
Perphenazine—HTR7—epithelium—skin cancer	0.000872	0.00891	CbGeAlD
Perphenazine—DRD1—head—skin cancer	0.000866	0.00885	CbGeAlD
Perphenazine—Pruritus—Vismodegib—skin cancer	0.000859	0.00637	CcSEcCtD
Perphenazine—Nasal congestion—Temozolomide—skin cancer	0.000856	0.00635	CcSEcCtD
Perphenazine—CALM2—skin of body—skin cancer	0.000853	0.00872	CbGeAlD
Perphenazine—CALM1—skin of body—skin cancer	0.000849	0.00867	CbGeAlD
Perphenazine—Diarrhoea—Vismodegib—skin cancer	0.000831	0.00616	CcSEcCtD
Perphenazine—Dermatitis exfoliative—Temozolomide—skin cancer	0.000827	0.00613	CcSEcCtD
Perphenazine—Photosensitivity—Fluorouracil—skin cancer	0.000819	0.00607	CcSEcCtD
Perphenazine—Amenorrhoea—Docetaxel—skin cancer	0.000814	0.00603	CcSEcCtD
Perphenazine—HTR2C—female reproductive system—skin cancer	0.000805	0.00823	CbGeAlD
Perphenazine—Cough—Vemurafenib—skin cancer	0.000802	0.00594	CcSEcCtD
Perphenazine—HTR2A—neck—skin cancer	0.000799	0.00817	CbGeAlD
Perphenazine—Oropharyngeal pain—Docetaxel—skin cancer	0.000786	0.00582	CcSEcCtD
Perphenazine—Erythema—Imiquimod—skin cancer	0.000784	0.00581	CcSEcCtD
Perphenazine—CALM2—mammalian vulva—skin cancer	0.000778	0.00795	CbGeAlD
Perphenazine—CALM1—mammalian vulva—skin cancer	0.000774	0.00791	CbGeAlD
Perphenazine—Pancytopenia—Bleomycin—skin cancer	0.000759	0.00562	CcSEcCtD
Perphenazine—Anaphylactic shock—Vemurafenib—skin cancer	0.00075	0.00556	CcSEcCtD
Perphenazine—Dysphagia—Dactinomycin—skin cancer	0.000746	0.00552	CcSEcCtD
Perphenazine—Infection—Vemurafenib—skin cancer	0.000745	0.00552	CcSEcCtD
Perphenazine—Ataxia—Temozolomide—skin cancer	0.000734	0.00544	CcSEcCtD
Perphenazine—Lethargy—Fluorouracil—skin cancer	0.000734	0.00543	CcSEcCtD
Perphenazine—Agitation—Imiquimod—skin cancer	0.000721	0.00534	CcSEcCtD
Perphenazine—Angioedema—Imiquimod—skin cancer	0.000716	0.00531	CcSEcCtD
Perphenazine—Hepatocellular injury—Docetaxel—skin cancer	0.000715	0.0053	CcSEcCtD
Perphenazine—Pancytopenia—Dactinomycin—skin cancer	0.000708	0.00525	CcSEcCtD
Perphenazine—Syncope—Imiquimod—skin cancer	0.000703	0.00521	CcSEcCtD
Perphenazine—Hypotension—Vemurafenib—skin cancer	0.000701	0.00519	CcSEcCtD
Perphenazine—CALM2—lymphoid tissue—skin cancer	0.00069	0.00706	CbGeAlD
Perphenazine—Loss of consciousness—Imiquimod—skin cancer	0.000689	0.00511	CcSEcCtD
Perphenazine—Muscular weakness—Temozolomide—skin cancer	0.000688	0.0051	CcSEcCtD
Perphenazine—CALM1—lymphoid tissue—skin cancer	0.000687	0.00702	CbGeAlD
Perphenazine—HRH1—connective tissue—skin cancer	0.000686	0.00701	CbGeAlD
Perphenazine—Cough—Imiquimod—skin cancer	0.000684	0.00507	CcSEcCtD
Perphenazine—Cardiac arrest—Fluorouracil—skin cancer	0.000684	0.00506	CcSEcCtD
Perphenazine—Convulsion—Imiquimod—skin cancer	0.000679	0.00503	CcSEcCtD
Perphenazine—Hypertension—Imiquimod—skin cancer	0.000677	0.00502	CcSEcCtD
Perphenazine—Ataxia—Fluorouracil—skin cancer	0.000676	0.00501	CcSEcCtD
Perphenazine—Dysphagia—Temozolomide—skin cancer	0.000674	0.005	CcSEcCtD
Perphenazine—ADRA2A—connective tissue—skin cancer	0.000673	0.00688	CbGeAlD
Perphenazine—HTR2C—head—skin cancer	0.000672	0.00687	CbGeAlD
Perphenazine—CALM2—female reproductive system—skin cancer	0.000666	0.00681	CbGeAlD
Perphenazine—CALM1—female reproductive system—skin cancer	0.000663	0.00678	CbGeAlD
Perphenazine—Dry mouth—Imiquimod—skin cancer	0.000653	0.00484	CcSEcCtD
Perphenazine—Decreased appetite—Vemurafenib—skin cancer	0.000652	0.00483	CcSEcCtD
Perphenazine—HRH1—epithelium—skin cancer	0.000651	0.00665	CbGeAlD
Perphenazine—HTR7—female reproductive system—skin cancer	0.000648	0.00662	CbGeAlD
Perphenazine—Constipation—Vemurafenib—skin cancer	0.000642	0.00475	CcSEcCtD
Perphenazine—Pancytopenia—Temozolomide—skin cancer	0.00064	0.00474	CcSEcCtD
Perphenazine—Hypoaesthesia—Bleomycin—skin cancer	0.000637	0.00472	CcSEcCtD
Perphenazine—Infection—Imiquimod—skin cancer	0.000636	0.00471	CcSEcCtD
Perphenazine—Muscular weakness—Fluorouracil—skin cancer	0.000634	0.0047	CcSEcCtD
Perphenazine—CYP2B6—skin of body—skin cancer	0.000634	0.00648	CbGeAlD
Perphenazine—Shock—Imiquimod—skin cancer	0.00063	0.00466	CcSEcCtD
Perphenazine—Tachycardia—Imiquimod—skin cancer	0.000625	0.00463	CcSEcCtD
Perphenazine—Dysphagia—Fluorouracil—skin cancer	0.000621	0.0046	CcSEcCtD
Perphenazine—Agranulocytosis—Dactinomycin—skin cancer	0.00062	0.0046	CcSEcCtD
Perphenazine—Photosensitivity reaction—Temozolomide—skin cancer	0.000616	0.00456	CcSEcCtD
Perphenazine—Eosinophilia—Fluorouracil—skin cancer	0.000615	0.00456	CcSEcCtD
Perphenazine—Anorexia—Imiquimod—skin cancer	0.00061	0.00452	CcSEcCtD
Perphenazine—Hyperglycaemia—Temozolomide—skin cancer	0.000608	0.00451	CcSEcCtD
Perphenazine—Body temperature increased—Vemurafenib—skin cancer	0.000593	0.00439	CcSEcCtD
Perphenazine—Pancytopenia—Fluorouracil—skin cancer	0.00059	0.00437	CcSEcCtD
Perphenazine—Insomnia—Imiquimod—skin cancer	0.000579	0.00429	CcSEcCtD
Perphenazine—HTR2A—connective tissue—skin cancer	0.000573	0.00585	CbGeAlD
Perphenazine—Dyspnoea—Imiquimod—skin cancer	0.000571	0.00423	CcSEcCtD
Perphenazine—Somnolence—Imiquimod—skin cancer	0.000569	0.00421	CcSEcCtD
Perphenazine—Photosensitivity reaction—Fluorouracil—skin cancer	0.000567	0.0042	CcSEcCtD
Perphenazine—HTR1A—head—skin cancer	0.000566	0.00579	CbGeAlD
Perphenazine—HRH1—mammalian vulva—skin cancer	0.000565	0.00577	CbGeAlD
Perphenazine—Erythema—Bleomycin—skin cancer	0.000557	0.00413	CcSEcCtD
Perphenazine—CALM2—head—skin cancer	0.000556	0.00569	CbGeAlD
Perphenazine—Decreased appetite—Imiquimod—skin cancer	0.000556	0.00412	CcSEcCtD
Perphenazine—ADRA2A—mammalian vulva—skin cancer	0.000555	0.00567	CbGeAlD
Perphenazine—CALM1—head—skin cancer	0.000554	0.00566	CbGeAlD
Perphenazine—Hypersensitivity—Vemurafenib—skin cancer	0.000553	0.0041	CcSEcCtD
Perphenazine—CYP2C8—female reproductive system—skin cancer	0.000552	0.00564	CbGeAlD
Perphenazine—AOX1—lymph node—skin cancer	0.000551	0.00563	CbGeAlD
Perphenazine—Pain—Imiquimod—skin cancer	0.000547	0.00405	CcSEcCtD
Perphenazine—HTR2A—epithelium—skin cancer	0.000544	0.00556	CbGeAlD
Perphenazine—HTR7—head—skin cancer	0.000541	0.00553	CbGeAlD
Perphenazine—Hypoaesthesia—Temozolomide—skin cancer	0.000537	0.00398	CcSEcCtD
Perphenazine—Oedema peripheral—Temozolomide—skin cancer	0.000532	0.00394	CcSEcCtD
Perphenazine—Pruritus—Vemurafenib—skin cancer	0.000531	0.00393	CcSEcCtD
Perphenazine—Lethargy—Docetaxel—skin cancer	0.000529	0.00392	CcSEcCtD
Perphenazine—Erythema—Dactinomycin—skin cancer	0.00052	0.00385	CcSEcCtD
Perphenazine—Agranulocytosis—Fluorouracil—skin cancer	0.000517	0.00383	CcSEcCtD
Perphenazine—Diarrhoea—Vemurafenib—skin cancer	0.000513	0.0038	CcSEcCtD
Perphenazine—CYP2B6—lymphoid tissue—skin cancer	0.000513	0.00525	CbGeAlD
Perphenazine—DRD2—head—skin cancer	0.000511	0.00523	CbGeAlD
Perphenazine—Urticaria—Imiquimod—skin cancer	0.000508	0.00377	CcSEcCtD
Perphenazine—Body temperature increased—Imiquimod—skin cancer	0.000506	0.00375	CcSEcCtD
Perphenazine—Leukopenia—Bleomycin—skin cancer	0.000499	0.00369	CcSEcCtD
Perphenazine—Dizziness—Vemurafenib—skin cancer	0.000496	0.00368	CcSEcCtD
Perphenazine—CALM3—lymph node—skin cancer	0.000496	0.00507	CbGeAlD
Perphenazine—CYP2B6—female reproductive system—skin cancer	0.000495	0.00506	CbGeAlD
Perphenazine—Hypoaesthesia—Fluorouracil—skin cancer	0.000495	0.00367	CcSEcCtD
Perphenazine—CYP2C9—female reproductive system—skin cancer	0.00049	0.00501	CbGeAlD
Perphenazine—Ataxia—Docetaxel—skin cancer	0.000488	0.00361	CcSEcCtD
Perphenazine—Cough—Bleomycin—skin cancer	0.000486	0.0036	CcSEcCtD
Perphenazine—HRH1—female reproductive system—skin cancer	0.000483	0.00494	CbGeAlD
Perphenazine—ADRA2A—female reproductive system—skin cancer	0.000475	0.00485	CbGeAlD
Perphenazine—Orthostatic hypotension—Docetaxel—skin cancer	0.000474	0.00351	CcSEcCtD
Perphenazine—Hypersensitivity—Imiquimod—skin cancer	0.000471	0.00349	CcSEcCtD
Perphenazine—Headache—Vemurafenib—skin cancer	0.00047	0.00348	CcSEcCtD
Perphenazine—Erythema—Temozolomide—skin cancer	0.00047	0.00348	CcSEcCtD
Perphenazine—Leukopenia—Dactinomycin—skin cancer	0.000465	0.00345	CcSEcCtD
Perphenazine—Confusional state—Bleomycin—skin cancer	0.000458	0.0034	CcSEcCtD
Perphenazine—Anaphylactic shock—Bleomycin—skin cancer	0.000455	0.00337	CcSEcCtD
Perphenazine—Pruritus—Imiquimod—skin cancer	0.000453	0.00335	CcSEcCtD
Perphenazine—Infection—Bleomycin—skin cancer	0.000452	0.00335	CcSEcCtD
Perphenazine—Dysphagia—Docetaxel—skin cancer	0.000448	0.00332	CcSEcCtD
Perphenazine—Vision blurred—Temozolomide—skin cancer	0.000443	0.00328	CcSEcCtD
Perphenazine—Diarrhoea—Imiquimod—skin cancer	0.000438	0.00324	CcSEcCtD
Perphenazine—Anorexia—Bleomycin—skin cancer	0.000433	0.00321	CcSEcCtD
Perphenazine—Erythema—Fluorouracil—skin cancer	0.000433	0.00321	CcSEcCtD
Perphenazine—Agitation—Temozolomide—skin cancer	0.000432	0.0032	CcSEcCtD
Perphenazine—Angioedema—Temozolomide—skin cancer	0.000429	0.00318	CcSEcCtD
Perphenazine—Pancytopenia—Docetaxel—skin cancer	0.000426	0.00316	CcSEcCtD
Perphenazine—Hypotension—Bleomycin—skin cancer	0.000425	0.00315	CcSEcCtD
Perphenazine—Dizziness—Imiquimod—skin cancer	0.000423	0.00314	CcSEcCtD
Perphenazine—Infection—Dactinomycin—skin cancer	0.000421	0.00312	CcSEcCtD
Perphenazine—Leukopenia—Temozolomide—skin cancer	0.000421	0.00312	CcSEcCtD
Perphenazine—CYP2B6—head—skin cancer	0.000414	0.00423	CbGeAlD
Perphenazine—Cough—Temozolomide—skin cancer	0.00041	0.00304	CcSEcCtD
Perphenazine—Vision blurred—Fluorouracil—skin cancer	0.000408	0.00302	CcSEcCtD
Perphenazine—Convulsion—Temozolomide—skin cancer	0.000407	0.00302	CcSEcCtD
Perphenazine—Hypertension—Temozolomide—skin cancer	0.000406	0.00301	CcSEcCtD
Perphenazine—Dyspnoea—Bleomycin—skin cancer	0.000405	0.003	CcSEcCtD
Perphenazine—Anorexia—Dactinomycin—skin cancer	0.000404	0.00299	CcSEcCtD
Perphenazine—HRH1—head—skin cancer	0.000404	0.00413	CbGeAlD
Perphenazine—HTR2A—female reproductive system—skin cancer	0.000404	0.00413	CbGeAlD
Perphenazine—Headache—Imiquimod—skin cancer	0.000401	0.00297	CcSEcCtD
Perphenazine—ADRA2A—head—skin cancer	0.000397	0.00406	CbGeAlD
Perphenazine—Decreased appetite—Bleomycin—skin cancer	0.000395	0.00293	CcSEcCtD
Perphenazine—Dry mouth—Temozolomide—skin cancer	0.000391	0.0029	CcSEcCtD
Perphenazine—Jaundice—Docetaxel—skin cancer	0.00039	0.00289	CcSEcCtD
Perphenazine—CALM2—lymph node—skin cancer	0.00039	0.00398	CbGeAlD
Perphenazine—Pain—Bleomycin—skin cancer	0.000389	0.00288	CcSEcCtD
Perphenazine—CALM1—lymph node—skin cancer	0.000388	0.00396	CbGeAlD
Perphenazine—Leukopenia—Fluorouracil—skin cancer	0.000388	0.00287	CcSEcCtD
Perphenazine—Confusional state—Temozolomide—skin cancer	0.000387	0.00286	CcSEcCtD
Perphenazine—Anaphylactic shock—Temozolomide—skin cancer	0.000383	0.00284	CcSEcCtD
Perphenazine—Infection—Temozolomide—skin cancer	0.000381	0.00282	CcSEcCtD
Perphenazine—Convulsion—Fluorouracil—skin cancer	0.000375	0.00278	CcSEcCtD
Perphenazine—CYP3A4—female reproductive system—skin cancer	0.000374	0.00382	CbGeAlD
Perphenazine—Agranulocytosis—Docetaxel—skin cancer	0.000373	0.00276	CcSEcCtD
Perphenazine—Decreased appetite—Dactinomycin—skin cancer	0.000369	0.00273	CcSEcCtD
Perphenazine—CYP2D6—female reproductive system—skin cancer	0.000368	0.00376	CbGeAlD
Perphenazine—Anorexia—Temozolomide—skin cancer	0.000366	0.00271	CcSEcCtD
Perphenazine—Pain—Dactinomycin—skin cancer	0.000363	0.00269	CcSEcCtD
Perphenazine—Urticaria—Bleomycin—skin cancer	0.000361	0.00268	CcSEcCtD
Perphenazine—Body temperature increased—Bleomycin—skin cancer	0.000359	0.00266	CcSEcCtD
Perphenazine—Hypoaesthesia—Docetaxel—skin cancer	0.000357	0.00265	CcSEcCtD
Perphenazine—Confusional state—Fluorouracil—skin cancer	0.000356	0.00264	CcSEcCtD
Perphenazine—Oedema peripheral—Docetaxel—skin cancer	0.000354	0.00262	CcSEcCtD
Perphenazine—Anaphylactic shock—Fluorouracil—skin cancer	0.000353	0.00262	CcSEcCtD
Perphenazine—Infection—Fluorouracil—skin cancer	0.000351	0.0026	CcSEcCtD
Perphenazine—Insomnia—Temozolomide—skin cancer	0.000347	0.00257	CcSEcCtD
Perphenazine—Tachycardia—Fluorouracil—skin cancer	0.000345	0.00255	CcSEcCtD
Perphenazine—Dyspnoea—Temozolomide—skin cancer	0.000342	0.00253	CcSEcCtD
Perphenazine—Somnolence—Temozolomide—skin cancer	0.000341	0.00253	CcSEcCtD
Perphenazine—HTR2A—head—skin cancer	0.000337	0.00345	CbGeAlD
Perphenazine—Anorexia—Fluorouracil—skin cancer	0.000337	0.0025	CcSEcCtD
Perphenazine—Body temperature increased—Dactinomycin—skin cancer	0.000335	0.00248	CcSEcCtD
Perphenazine—Hypersensitivity—Bleomycin—skin cancer	0.000335	0.00248	CcSEcCtD
Perphenazine—Decreased appetite—Temozolomide—skin cancer	0.000333	0.00247	CcSEcCtD
Perphenazine—Hypotension—Fluorouracil—skin cancer	0.00033	0.00245	CcSEcCtD
Perphenazine—Pain—Temozolomide—skin cancer	0.000328	0.00243	CcSEcCtD
Perphenazine—Constipation—Temozolomide—skin cancer	0.000328	0.00243	CcSEcCtD
Perphenazine—Pruritus—Bleomycin—skin cancer	0.000322	0.00238	CcSEcCtD
Perphenazine—Insomnia—Fluorouracil—skin cancer	0.00032	0.00237	CcSEcCtD
Perphenazine—Dyspnoea—Fluorouracil—skin cancer	0.000315	0.00233	CcSEcCtD
Perphenazine—Somnolence—Fluorouracil—skin cancer	0.000314	0.00233	CcSEcCtD
Perphenazine—Erythema—Docetaxel—skin cancer	0.000312	0.00231	CcSEcCtD
Perphenazine—Hypersensitivity—Dactinomycin—skin cancer	0.000312	0.00231	CcSEcCtD
Perphenazine—CYP2D6—head—skin cancer	0.000307	0.00314	CbGeAlD
Perphenazine—Decreased appetite—Fluorouracil—skin cancer	0.000307	0.00228	CcSEcCtD
Perphenazine—Urticaria—Temozolomide—skin cancer	0.000305	0.00226	CcSEcCtD
Perphenazine—Body temperature increased—Temozolomide—skin cancer	0.000303	0.00225	CcSEcCtD
Perphenazine—Pain—Fluorouracil—skin cancer	0.000302	0.00224	CcSEcCtD
Perphenazine—Muscle spasms—Docetaxel—skin cancer	0.0003	0.00223	CcSEcCtD
Perphenazine—Diarrhoea—Dactinomycin—skin cancer	0.00029	0.00215	CcSEcCtD
Perphenazine—HRH1—lymph node—skin cancer	0.000283	0.00289	CbGeAlD
Perphenazine—Hypersensitivity—Temozolomide—skin cancer	0.000283	0.00209	CcSEcCtD
Perphenazine—Urticaria—Fluorouracil—skin cancer	0.000281	0.00208	CcSEcCtD
Perphenazine—Syncope—Docetaxel—skin cancer	0.00028	0.00208	CcSEcCtD
Perphenazine—Leukopenia—Docetaxel—skin cancer	0.00028	0.00207	CcSEcCtD
Perphenazine—Body temperature increased—Fluorouracil—skin cancer	0.000279	0.00207	CcSEcCtD
Perphenazine—ADRA2A—lymph node—skin cancer	0.000278	0.00284	CbGeAlD
Perphenazine—Loss of consciousness—Docetaxel—skin cancer	0.000275	0.00203	CcSEcCtD
Perphenazine—Cough—Docetaxel—skin cancer	0.000273	0.00202	CcSEcCtD
Perphenazine—Pruritus—Temozolomide—skin cancer	0.000271	0.00201	CcSEcCtD
Perphenazine—Convulsion—Docetaxel—skin cancer	0.000271	0.00201	CcSEcCtD
Perphenazine—Hypertension—Docetaxel—skin cancer	0.00027	0.002	CcSEcCtD
Perphenazine—Diarrhoea—Temozolomide—skin cancer	0.000262	0.00194	CcSEcCtD
Perphenazine—Hypersensitivity—Fluorouracil—skin cancer	0.00026	0.00193	CcSEcCtD
Perphenazine—Dry mouth—Docetaxel—skin cancer	0.00026	0.00193	CcSEcCtD
Perphenazine—Confusional state—Docetaxel—skin cancer	0.000257	0.00191	CcSEcCtD
Perphenazine—Anaphylactic shock—Docetaxel—skin cancer	0.000255	0.00189	CcSEcCtD
Perphenazine—Dizziness—Temozolomide—skin cancer	0.000254	0.00188	CcSEcCtD
Perphenazine—Infection—Docetaxel—skin cancer	0.000253	0.00188	CcSEcCtD
Perphenazine—Shock—Docetaxel—skin cancer	0.000251	0.00186	CcSEcCtD
Perphenazine—Pruritus—Fluorouracil—skin cancer	0.00025	0.00185	CcSEcCtD
Perphenazine—Tachycardia—Docetaxel—skin cancer	0.000249	0.00184	CcSEcCtD
Perphenazine—Anorexia—Docetaxel—skin cancer	0.000243	0.0018	CcSEcCtD
Perphenazine—Diarrhoea—Fluorouracil—skin cancer	0.000242	0.00179	CcSEcCtD
Perphenazine—Headache—Temozolomide—skin cancer	0.00024	0.00178	CcSEcCtD
Perphenazine—Hypotension—Docetaxel—skin cancer	0.000238	0.00177	CcSEcCtD
Perphenazine—Dizziness—Fluorouracil—skin cancer	0.000234	0.00173	CcSEcCtD
Perphenazine—Insomnia—Docetaxel—skin cancer	0.000231	0.00171	CcSEcCtD
Perphenazine—Dyspnoea—Docetaxel—skin cancer	0.000227	0.00168	CcSEcCtD
Perphenazine—Somnolence—Docetaxel—skin cancer	0.000227	0.00168	CcSEcCtD
Perphenazine—Decreased appetite—Docetaxel—skin cancer	0.000222	0.00164	CcSEcCtD
Perphenazine—Headache—Fluorouracil—skin cancer	0.000221	0.00164	CcSEcCtD
Perphenazine—Pain—Docetaxel—skin cancer	0.000218	0.00162	CcSEcCtD
Perphenazine—Constipation—Docetaxel—skin cancer	0.000218	0.00162	CcSEcCtD
Perphenazine—Body temperature increased—Docetaxel—skin cancer	0.000202	0.00149	CcSEcCtD
Perphenazine—Hypersensitivity—Docetaxel—skin cancer	0.000188	0.00139	CcSEcCtD
Perphenazine—Pruritus—Docetaxel—skin cancer	0.00018	0.00134	CcSEcCtD
Perphenazine—Diarrhoea—Docetaxel—skin cancer	0.000174	0.00129	CcSEcCtD
Perphenazine—Dizziness—Docetaxel—skin cancer	0.000169	0.00125	CcSEcCtD
Perphenazine—Headache—Docetaxel—skin cancer	0.00016	0.00118	CcSEcCtD
Perphenazine—CALM1—Neuronal System—HRAS—skin cancer	1.83e-05	0.00023	CbGpPWpGaD
Perphenazine—CALM2—Neuronal System—HRAS—skin cancer	1.83e-05	0.00023	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—FOXO4—skin cancer	1.79e-05	0.000225	CbGpPWpGaD
Perphenazine—CALM1—Signaling by NGF—HRAS—skin cancer	1.79e-05	0.000225	CbGpPWpGaD
Perphenazine—CALM2—Signaling by NGF—HRAS—skin cancer	1.79e-05	0.000225	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—PTGER4—skin cancer	1.79e-05	0.000225	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—PTGER4—skin cancer	1.79e-05	0.000225	CbGpPWpGaD
Perphenazine—CALM3—Signaling by NGF—IL6—skin cancer	1.77e-05	0.000223	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—TERT—skin cancer	1.77e-05	0.000223	CbGpPWpGaD
Perphenazine—ADRA2A—Hemostasis—NRAS—skin cancer	1.76e-05	0.000221	CbGpPWpGaD
Perphenazine—AOX1—Disease—HRAS—skin cancer	1.76e-05	0.000221	CbGpPWpGaD
Perphenazine—CYP2C18—Metabolism—PTGS2—skin cancer	1.74e-05	0.00022	CbGpPWpGaD
Perphenazine—HTR6—Signaling by GPCR—NRAS—skin cancer	1.73e-05	0.000218	CbGpPWpGaD
Perphenazine—HTR7—Signaling by GPCR—NRAS—skin cancer	1.73e-05	0.000218	CbGpPWpGaD
Perphenazine—CALM2—Signaling by NGF—IL6—skin cancer	1.71e-05	0.000216	CbGpPWpGaD
Perphenazine—CALM1—Signaling by NGF—IL6—skin cancer	1.71e-05	0.000216	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—ENO2—skin cancer	1.71e-05	0.000215	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—ENO2—skin cancer	1.7e-05	0.000214	CbGpPWpGaD
Perphenazine—AOX1—Disease—IL6—skin cancer	1.68e-05	0.000211	CbGpPWpGaD
Perphenazine—CALM3—Disease—ERCC2—skin cancer	1.66e-05	0.000209	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—CSPG4—skin cancer	1.65e-05	0.000207	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—FOXO4—skin cancer	1.63e-05	0.000206	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.63e-05	0.000205	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—BRAF—skin cancer	1.63e-05	0.000205	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—BRAF—skin cancer	1.63e-05	0.000205	CbGpPWpGaD
Perphenazine—CALM2—Disease—ERCC2—skin cancer	1.61e-05	0.000202	CbGpPWpGaD
Perphenazine—CALM1—Disease—ERCC2—skin cancer	1.61e-05	0.000202	CbGpPWpGaD
Perphenazine—CALM3—Hemostasis—NRAS—skin cancer	1.6e-05	0.000202	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—FOXO4—skin cancer	1.58e-05	0.000199	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—FOXO4—skin cancer	1.58e-05	0.000199	CbGpPWpGaD
Perphenazine—CALM3—Disease—TERT—skin cancer	1.56e-05	0.000196	CbGpPWpGaD
Perphenazine—CALM2—Hemostasis—NRAS—skin cancer	1.55e-05	0.000195	CbGpPWpGaD
Perphenazine—CALM1—Hemostasis—NRAS—skin cancer	1.55e-05	0.000195	CbGpPWpGaD
Perphenazine—ADRA2A—Metabolism—ERCC2—skin cancer	1.53e-05	0.000192	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—TERT—skin cancer	1.52e-05	0.000191	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—TERT—skin cancer	1.51e-05	0.00019	CbGpPWpGaD
Perphenazine—ADRA2A—Hemostasis—KRAS—skin cancer	1.51e-05	0.00019	CbGpPWpGaD
Perphenazine—CALM1—Disease—TERT—skin cancer	1.51e-05	0.00019	CbGpPWpGaD
Perphenazine—CALM2—Disease—TERT—skin cancer	1.51e-05	0.00019	CbGpPWpGaD
Perphenazine—DRD1—Signaling by GPCR—NRAS—skin cancer	1.49e-05	0.000188	CbGpPWpGaD
Perphenazine—HTR6—Signaling by GPCR—KRAS—skin cancer	1.49e-05	0.000188	CbGpPWpGaD
Perphenazine—HTR7—Signaling by GPCR—KRAS—skin cancer	1.49e-05	0.000187	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.46e-05	0.000183	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—ENO2—skin cancer	1.45e-05	0.000182	CbGpPWpGaD
Perphenazine—CALM3—Innate Immune System—NRAS—skin cancer	1.44e-05	0.000181	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—ERCC2—skin cancer	1.43e-05	0.00018	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—BRAF—skin cancer	1.4e-05	0.000176	CbGpPWpGaD
Perphenazine—CALM2—Innate Immune System—NRAS—skin cancer	1.39e-05	0.000176	CbGpPWpGaD
Perphenazine—CALM1—Innate Immune System—NRAS—skin cancer	1.39e-05	0.000176	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—ERCC2—skin cancer	1.39e-05	0.000175	CbGpPWpGaD
Perphenazine—CALM3—Adaptive Immune System—NRAS—skin cancer	1.38e-05	0.000174	CbGpPWpGaD
Perphenazine—CALM3—Hemostasis—KRAS—skin cancer	1.38e-05	0.000173	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—ERCC2—skin cancer	1.35e-05	0.000169	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—ERCC2—skin cancer	1.35e-05	0.000169	CbGpPWpGaD
Perphenazine—ADRA2A—Hemostasis—TP53—skin cancer	1.34e-05	0.000169	CbGpPWpGaD
Perphenazine—CALM1—Adaptive Immune System—NRAS—skin cancer	1.34e-05	0.000169	CbGpPWpGaD
Perphenazine—CALM2—Adaptive Immune System—NRAS—skin cancer	1.34e-05	0.000169	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—TERT—skin cancer	1.34e-05	0.000168	CbGpPWpGaD
Perphenazine—CALM1—Hemostasis—KRAS—skin cancer	1.33e-05	0.000168	CbGpPWpGaD
Perphenazine—CALM2—Hemostasis—KRAS—skin cancer	1.33e-05	0.000168	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.33e-05	0.000167	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—TERT—skin cancer	1.31e-05	0.000165	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—TERT—skin cancer	1.31e-05	0.000165	CbGpPWpGaD
Perphenazine—ADRA2A—Hemostasis—HRAS—skin cancer	1.28e-05	0.000162	CbGpPWpGaD
Perphenazine—DRD1—Signaling by GPCR—KRAS—skin cancer	1.28e-05	0.000161	CbGpPWpGaD
Perphenazine—HTR1A—Signaling by GPCR—NRAS—skin cancer	1.28e-05	0.000161	CbGpPWpGaD
Perphenazine—HTR2C—Signaling by GPCR—NRAS—skin cancer	1.28e-05	0.00016	CbGpPWpGaD
Perphenazine—HTR6—Signaling by GPCR—HRAS—skin cancer	1.27e-05	0.000159	CbGpPWpGaD
Perphenazine—HTR7—Signaling by GPCR—HRAS—skin cancer	1.27e-05	0.000159	CbGpPWpGaD
Perphenazine—CALM3—Innate Immune System—KRAS—skin cancer	1.24e-05	0.000156	CbGpPWpGaD
Perphenazine—CALM3—Disease—BRAF—skin cancer	1.23e-05	0.000155	CbGpPWpGaD
Perphenazine—CALM3—Hemostasis—TP53—skin cancer	1.23e-05	0.000154	CbGpPWpGaD
Perphenazine—HTR6—Signaling by GPCR—IL6—skin cancer	1.21e-05	0.000153	CbGpPWpGaD
Perphenazine—HTR7—Signaling by GPCR—IL6—skin cancer	1.21e-05	0.000152	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—ERCC2—skin cancer	1.21e-05	0.000152	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—BRAF—skin cancer	1.2e-05	0.000152	CbGpPWpGaD
Perphenazine—CALM1—Innate Immune System—KRAS—skin cancer	1.2e-05	0.000151	CbGpPWpGaD
Perphenazine—CALM2—Innate Immune System—KRAS—skin cancer	1.2e-05	0.000151	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—BRAF—skin cancer	1.2e-05	0.000151	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—TERT—skin cancer	1.2e-05	0.00015	CbGpPWpGaD
Perphenazine—CALM2—Disease—BRAF—skin cancer	1.19e-05	0.00015	CbGpPWpGaD
Perphenazine—CALM1—Disease—BRAF—skin cancer	1.19e-05	0.00015	CbGpPWpGaD
Perphenazine—CALM3—Adaptive Immune System—KRAS—skin cancer	1.19e-05	0.00015	CbGpPWpGaD
Perphenazine—CALM1—Hemostasis—TP53—skin cancer	1.19e-05	0.000149	CbGpPWpGaD
Perphenazine—CALM2—Hemostasis—TP53—skin cancer	1.19e-05	0.000149	CbGpPWpGaD
Perphenazine—CALM3—Hemostasis—HRAS—skin cancer	1.17e-05	0.000147	CbGpPWpGaD
Perphenazine—CALM2—Adaptive Immune System—KRAS—skin cancer	1.15e-05	0.000145	CbGpPWpGaD
Perphenazine—CALM1—Adaptive Immune System—KRAS—skin cancer	1.15e-05	0.000145	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.13e-05	0.000143	CbGpPWpGaD
Perphenazine—CALM2—Hemostasis—HRAS—skin cancer	1.13e-05	0.000143	CbGpPWpGaD
Perphenazine—CALM1—Hemostasis—HRAS—skin cancer	1.13e-05	0.000143	CbGpPWpGaD
Perphenazine—DRD2—Signaling by GPCR—NRAS—skin cancer	1.13e-05	0.000142	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—ENO2—skin cancer	1.12e-05	0.000141	CbGpPWpGaD
Perphenazine—HTR2A—Signaling by GPCR—NRAS—skin cancer	1.11e-05	0.000139	CbGpPWpGaD
Perphenazine—HRH1—Signaling by GPCR—NRAS—skin cancer	1.1e-05	0.000139	CbGpPWpGaD
Perphenazine—HTR1A—Signaling by GPCR—KRAS—skin cancer	1.1e-05	0.000139	CbGpPWpGaD
Perphenazine—HTR2C—Signaling by GPCR—KRAS—skin cancer	1.1e-05	0.000138	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—TERT—skin cancer	1.09e-05	0.000137	CbGpPWpGaD
Perphenazine—DRD1—Signaling by GPCR—HRAS—skin cancer	1.09e-05	0.000137	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—ERCC2—skin cancer	1.08e-05	0.000136	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—BRAF—skin cancer	1.06e-05	0.000133	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—TERT—skin cancer	1.06e-05	0.000133	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—TERT—skin cancer	1.06e-05	0.000133	CbGpPWpGaD
Perphenazine—CALM3—Innate Immune System—HRAS—skin cancer	1.05e-05	0.000133	CbGpPWpGaD
Perphenazine—DRD1—Signaling by GPCR—IL6—skin cancer	1.04e-05	0.000131	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—BRAF—skin cancer	1.04e-05	0.000131	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—BRAF—skin cancer	1.04e-05	0.000131	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—NRAS—skin cancer	1.02e-05	0.000129	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—NRAS—skin cancer	1.02e-05	0.000129	CbGpPWpGaD
Perphenazine—CALM2—Innate Immune System—HRAS—skin cancer	1.02e-05	0.000128	CbGpPWpGaD
Perphenazine—CALM1—Innate Immune System—HRAS—skin cancer	1.02e-05	0.000128	CbGpPWpGaD
Perphenazine—CALM3—Adaptive Immune System—HRAS—skin cancer	1.01e-05	0.000127	CbGpPWpGaD
Perphenazine—CALM3—Innate Immune System—IL6—skin cancer	1.01e-05	0.000127	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—NRAS—skin cancer	1.01e-05	0.000127	CbGpPWpGaD
Perphenazine—CALM3—Disease—PTGS2—skin cancer	9.97e-06	0.000125	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—ERCC2—skin cancer	9.94e-06	0.000125	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—ERCC2—skin cancer	9.86e-06	0.000124	CbGpPWpGaD
Perphenazine—CALM2—Adaptive Immune System—HRAS—skin cancer	9.8e-06	0.000123	CbGpPWpGaD
Perphenazine—CALM1—Adaptive Immune System—HRAS—skin cancer	9.8e-06	0.000123	CbGpPWpGaD
Perphenazine—CALM1—Innate Immune System—IL6—skin cancer	9.77e-06	0.000123	CbGpPWpGaD
Perphenazine—CALM2—Innate Immune System—IL6—skin cancer	9.77e-06	0.000123	CbGpPWpGaD
Perphenazine—DRD2—Signaling by GPCR—KRAS—skin cancer	9.69e-06	0.000122	CbGpPWpGaD
Perphenazine—CALM2—Disease—PTGS2—skin cancer	9.64e-06	0.000121	CbGpPWpGaD
Perphenazine—CALM1—Disease—PTGS2—skin cancer	9.64e-06	0.000121	CbGpPWpGaD
Perphenazine—HTR2A—Signaling by GPCR—KRAS—skin cancer	9.53e-06	0.00012	CbGpPWpGaD
Perphenazine—HRH1—Signaling by GPCR—KRAS—skin cancer	9.51e-06	0.00012	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—BRAF—skin cancer	9.47e-06	0.000119	CbGpPWpGaD
Perphenazine—HTR1A—Signaling by GPCR—HRAS—skin cancer	9.38e-06	0.000118	CbGpPWpGaD
Perphenazine—HTR2C—Signaling by GPCR—HRAS—skin cancer	9.33e-06	0.000117	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—NRAS—skin cancer	9.19e-06	0.000116	CbGpPWpGaD
Perphenazine—ADRA2A—Metabolism—PTGS2—skin cancer	9.15e-06	0.000115	CbGpPWpGaD
Perphenazine—HTR1A—Signaling by GPCR—IL6—skin cancer	8.98e-06	0.000113	CbGpPWpGaD
Perphenazine—HTR2C—Signaling by GPCR—IL6—skin cancer	8.93e-06	0.000112	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—NRAS—skin cancer	8.89e-06	0.000112	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—NRAS—skin cancer	8.89e-06	0.000112	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—NRAS—skin cancer	8.81e-06	0.000111	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—KRAS—skin cancer	8.8e-06	0.000111	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—KRAS—skin cancer	8.79e-06	0.000111	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—KRAS—skin cancer	8.67e-06	0.000109	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—BRAF—skin cancer	8.64e-06	0.000109	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—PTGS2—skin cancer	8.58e-06	0.000108	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—ERCC2—skin cancer	8.42e-06	0.000106	CbGpPWpGaD
Perphenazine—CALM3—Immune System—NRAS—skin cancer	8.4e-06	0.000106	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—BRAF—skin cancer	8.36e-06	0.000105	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—BRAF—skin cancer	8.36e-06	0.000105	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—PTGS2—skin cancer	8.35e-06	0.000105	CbGpPWpGaD
Perphenazine—DRD2—Signaling by GPCR—HRAS—skin cancer	8.23e-06	0.000104	CbGpPWpGaD
Perphenazine—CALM2—Immune System—NRAS—skin cancer	8.12e-06	0.000102	CbGpPWpGaD
Perphenazine—CALM1—Immune System—NRAS—skin cancer	8.12e-06	0.000102	CbGpPWpGaD
Perphenazine—HTR2A—Signaling by GPCR—HRAS—skin cancer	8.1e-06	0.000102	CbGpPWpGaD
Perphenazine—HRH1—Signaling by GPCR—HRAS—skin cancer	8.08e-06	0.000102	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—PTGS2—skin cancer	8.07e-06	0.000102	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—PTGS2—skin cancer	8.07e-06	0.000102	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—KRAS—skin cancer	7.91e-06	9.96e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling by GPCR—IL6—skin cancer	7.88e-06	9.92e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—TP53—skin cancer	7.82e-06	9.85e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—TP53—skin cancer	7.82e-06	9.84e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—NRAS—skin cancer	7.75e-06	9.76e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling by GPCR—IL6—skin cancer	7.75e-06	9.76e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling by GPCR—IL6—skin cancer	7.74e-06	9.74e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—KRAS—skin cancer	7.65e-06	9.63e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—KRAS—skin cancer	7.65e-06	9.63e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—KRAS—skin cancer	7.58e-06	9.54e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—NRAS—skin cancer	7.57e-06	9.53e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—NRAS—skin cancer	7.53e-06	9.48e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—NRAS—skin cancer	7.5e-06	9.44e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—NRAS—skin cancer	7.5e-06	9.44e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—HRAS—skin cancer	7.48e-06	9.42e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—HRAS—skin cancer	7.48e-06	9.41e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—HRAS—skin cancer	7.37e-06	9.28e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—PTGS2—skin cancer	7.26e-06	9.14e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—KRAS—skin cancer	7.23e-06	9.1e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—IL6—skin cancer	7.16e-06	9.01e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—IL6—skin cancer	7.15e-06	9e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—IL6—skin cancer	7.05e-06	8.88e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—KRAS—skin cancer	6.99e-06	8.8e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—KRAS—skin cancer	6.99e-06	8.8e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—TP53—skin cancer	6.74e-06	8.48e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—HRAS—skin cancer	6.72e-06	8.46e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—KRAS—skin cancer	6.67e-06	8.4e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—NRAS—skin cancer	6.65e-06	8.37e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—NRAS—skin cancer	6.54e-06	8.23e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—NRAS—skin cancer	6.53e-06	8.21e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—KRAS—skin cancer	6.52e-06	8.2e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—HRAS—skin cancer	6.51e-06	8.19e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—HRAS—skin cancer	6.51e-06	8.19e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—ERCC2—skin cancer	6.5e-06	8.18e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—KRAS—skin cancer	6.48e-06	8.16e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—PTGS2—skin cancer	6.48e-06	8.16e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—KRAS—skin cancer	6.46e-06	8.12e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—KRAS—skin cancer	6.46e-06	8.12e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—HRAS—skin cancer	6.44e-06	8.11e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—IL6—skin cancer	6.44e-06	8.1e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—IL6—skin cancer	6.23e-06	7.84e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—IL6—skin cancer	6.23e-06	7.84e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—IL6—skin cancer	6.17e-06	7.76e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—HRAS—skin cancer	6.14e-06	7.73e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—PTGS2—skin cancer	5.96e-06	7.5e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—NRAS—skin cancer	5.95e-06	7.49e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—HRAS—skin cancer	5.94e-06	7.48e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—HRAS—skin cancer	5.94e-06	7.48e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—PTGS2—skin cancer	5.91e-06	7.44e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—IL6—skin cancer	5.88e-06	7.4e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—TP53—skin cancer	5.79e-06	7.29e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—TP53—skin cancer	5.76e-06	7.25e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—KRAS—skin cancer	5.72e-06	7.2e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—IL6—skin cancer	5.69e-06	7.16e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—IL6—skin cancer	5.69e-06	7.16e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—HRAS—skin cancer	5.67e-06	7.14e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—KRAS—skin cancer	5.63e-06	7.09e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—KRAS—skin cancer	5.62e-06	7.07e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—HRAS—skin cancer	5.54e-06	6.97e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—HRAS—skin cancer	5.51e-06	6.94e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—HRAS—skin cancer	5.49e-06	6.91e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—HRAS—skin cancer	5.49e-06	6.91e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—NRAS—skin cancer	5.43e-06	6.83e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—IL6—skin cancer	5.43e-06	6.83e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—IL6—skin cancer	5.3e-06	6.67e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—IL6—skin cancer	5.27e-06	6.64e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—NRAS—skin cancer	5.25e-06	6.61e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—NRAS—skin cancer	5.25e-06	6.61e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—IL6—skin cancer	5.25e-06	6.61e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—IL6—skin cancer	5.25e-06	6.61e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—KRAS—skin cancer	5.12e-06	6.45e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—TP53—skin cancer	5.09e-06	6.4e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PTGS2—skin cancer	5.05e-06	6.35e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—TP53—skin cancer	5e-06	6.3e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—TP53—skin cancer	4.99e-06	6.28e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—HRAS—skin cancer	4.86e-06	6.12e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—HRAS—skin cancer	4.79e-06	6.02e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—HRAS—skin cancer	4.78e-06	6.01e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—KRAS—skin cancer	4.67e-06	5.88e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—IL6—skin cancer	4.66e-06	5.86e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—IL6—skin cancer	4.58e-06	5.76e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—IL6—skin cancer	4.57e-06	5.75e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—TP53—skin cancer	4.55e-06	5.73e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—KRAS—skin cancer	4.52e-06	5.69e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—KRAS—skin cancer	4.52e-06	5.69e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—HRAS—skin cancer	4.35e-06	5.48e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—IL6—skin cancer	4.17e-06	5.24e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—TP53—skin cancer	4.15e-06	5.23e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—TP53—skin cancer	4.02e-06	5.06e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—TP53—skin cancer	4.02e-06	5.06e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—HRAS—skin cancer	3.97e-06	5e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PTGS2—skin cancer	3.9e-06	4.9e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—HRAS—skin cancer	3.84e-06	4.84e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—HRAS—skin cancer	3.84e-06	4.84e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—IL6—skin cancer	3.8e-06	4.78e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—IL6—skin cancer	3.68e-06	4.63e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—IL6—skin cancer	3.68e-06	4.63e-05	CbGpPWpGaD
